CN
| ID | Title |
| 4080 | Mutation of DNA damage repair genes confers an immune-privileged tumor microenvironment in colorectal cancer with a prognostic value |
| e16014 | Effect of TP53 mutation on antitumor immunity and responsiveness to immunotherapy in colorectal cancer |
| e15044 | Peripheral cytokine as a pan-cancer predictor for immunotherapy with anti-PD-1/PD-L1 antibody |
| e16635 | A risk scoring system to predict overall survival for patients with liver cancer |
| e16579 | The mutational pattern of homologous recombination (HR) related genes and its relevance to response to immunotherapy in gastric cancer |
| 4076 | The mutation of homologous recombination repair genetics is a biomarker for immunotherapy in microsatellite stable colon cancer |
| e21003 | The association of CD8+ T-cell infiltration and PD-L1 expression with prognosis of Chinese pulmonary large cell neuroendocrine carcinoma |
| e13671 | Application of MammaPrint test on Chinese patient with breast cancer |
| e13673 | Ki-67 versus MammaPrint/BluePrint for assessing Luminal type breast cancer |
| e13687 | A DNA-mutational panel for liquid biopsy-based pan-cancer early detection |
| e13555 | MLsurvival: an automated machine learning tool for survival analysis of cancer patients |
| e13554 | DNA methylation profile in unknown cancer origin identification: a multi-class classification model |
| 1550 | A noninvasive multi-analytic approach for lung cancer screening of patients with pulmonary nodules |
| e16551 | Association of HLA Class I genotype with Outcomes of Gastrointestinal Cancer Patients with Immunotherapy |
| e15013 | A pilot trial of multiple-TSA-specific adoptive immune cell (MAIC) as adjuvant therapy in gastrointestinal cancer |
East Building #20, 20 Xiushui Road, CMC, Taizhou, P.R. China